Phase 1-2 study of TI-061 alone and in combination with other anti-cancer agents in patients with advanced malignancies.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.tps3109
Abstract: TPS3109Background: The cell surface protein CD47 is expressed or over-expressed on many tumor types. CD47 binds to signal regulatory protein alpha (SIRPα) on macrophages resulting in a “don’t eat m... read more here.
Keywords: alone combination; anti cancer; combination anti; phase study ... See more keywords